CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes

Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes.

To determine the ability of semi-automated plaque assessment in cardiac computed tomography angiography (CCTA) and high sensitive troponin T (hsTnT) for the risk stratification of patients at intermediate risk for coronary artery disease (CAD).

Inclusion Criteria:

• Clinical indication for CCTA according to the current appropriate use criteria

Exclusion Criteria:

• non-sinus rhythm
• acute coronary syndromes
• cardiomyopathies
• moderate or severe valvular disease
• elevated serum creatinine (>1.5 mg/dl)
• history or ECG signs of previous myocardial infarction
• severe iodine allergy.